We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Barcode Technology to Help Diagnose Cancer More Precisely

By LabMedica International staff writers
Posted on 22 Nov 2024
Print article
Image: Patho-DBiT reveals cellular level tissue architecture of an aggressive gastric lymphoma sample stored for 3 years (Photo courtesy of Yale)
Image: Patho-DBiT reveals cellular level tissue architecture of an aggressive gastric lymphoma sample stored for 3 years (Photo courtesy of Yale)

A new pathology tool utilizing barcode technology shows promise for use in cancer diagnoses.

Developed at Yale School of Medicine (New Haven, CT, USA), this tool, called Patho-DBiT (pathology-compatible deterministic barcoding in tissue), leverages DNA barcoding to map the spatial relationships between RNA and proteins, enabling a comprehensive examination of RNA, some types of which play regulatory roles in cancer. The innovation lies in its use of microfluidic devices that deliver barcodes into tissue from two directions, creating a unique 2D “mosaic” of pixels. This mosaic provides spatial information that could be crucial for developing patient-specific targeted therapies.

In their study published in the journal Cell, the researchers explain how Patho-DBiT could unlock a vast amount of information preserved in tissue biopsy samples. Potential future applications of this technology include the creation of targeted therapies and understanding the mechanisms behind the transformation of low-grade tumors into more aggressive forms, which could help find ways to prevent this progression. However, further research is required to test and validate patient samples before Patho-DBiT can be integrated into routine pathology diagnostics.

“It’s the first time we can directly ‘see’ all kinds of RNA species, where they are and what they do, in clinical tissue samples,” said Yale’s Rong Fan, PhD, senior author of the study. “Using this tool, we’re able to better understand the fascinating biology of each RNA molecule which has a very rich life cycle beyond just knowing whether each gene is expressed or not. I think it’s going to completely transform how we study the biology of humans in the future.”

“There are millions of these tissues that have been archived for so many years, but up until now, we didn’t have effective tools to investigate them at spatial level,” said the study’s first author Zhiliang Bai, PhD, a postdoctoral associate in Fan’s lab. “RNA molecules in these tissues we’re looking at are highly fragmented and traditional methods can’t capture all the important information about them. It’s why we’re very excited about Patho-DBiT.”

New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Hematology Analyzer
BH-6180
New
Urine Drug Test
Instant-view Buprenorphine Urine Drug Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Three newly identified protein biomarkers have the potential to improve diagnostic tools for colorectal cancer (Photo courtesy of Adobe Stock)

New Protein Biomarkers to Improve Diagnostic Tools for Colorectal Cancer

Colorectal cancer is a leading cause of cancer-related deaths globally, and its incidence is expected to rise in the coming decades. This cancer begins when abnormal cells grow uncontrollably in the large... Read more

Microbiology

view channel
Image: The CRISPR-TB Blood Test provides accurate, rapid, and cost-effective diagnosis (Photo courtesy of 123RF)

CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening

Tuberculosis (TB) continues to be a leading cause of global mortality, with 10.6 million new cases and 1.6 million deaths annually. Diagnosing TB remains difficult, with smear microscopy offering only... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.